Resolute Integrity Coronary Stent System
FDA premarket approval P110013/S112 · decided 2022-01-27
Approval details
- PMA number
- P110013
- Supplement
- S112
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Resolute Integrity Coronary Stent System
- Generic name
- Coronary drug-eluting stent
- Applicant
- Medtronic Vascular
- Date received
- 2021-05-17
- Decision date
- 2022-01-27
- Days to decision
- 255 days
- Decision code
- APPR
- Product code
- NIQ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Approval for using calculations of spore log resistance to evaluate lethality challenges of the requalification microbiological performance qualification for process development.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.